← SynDRA
BETAMETHASONE DIPROPIONATE
SynDRA canonical compound SYN0022954 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NR3C1 |
|---|
| Mechanism of action | anti-inflammatory agent |
|---|
| Indication | corticosteroid-responsive dermatoses |
|---|
| Disease area | dermatology |
|---|
All known targets
- NR3C1
- Nr3c1
- ANXA1
- HRH1
- CHRM1
- CHRM3
- CHRM4
- CHRM5
Mechanisms of action (all sources)
- NR3C1 AGONIST
- NR3C1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- ESR1
- DRD2
- PGR
- NPY1R
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- ADORA1
- HRH2
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- POLK
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HRH3
- HDAC6
- HRH1
- ADORA2A
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- APEX1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Inflammatory Agents
- Anti-Asthmatic Agents
- Glucocorticoids
- Hormones
- Respiratory System Agents
- anti-inflammatory agent
ATC classes
- D07A · CORTICOSTEROIDS, PLAIN
- D07X · CORTICOSTEROIDS, OTHER COMBINATIONS
- H02A · CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
- S02B · CORTICOSTEROIDS
- S01C · ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
- R03B · OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
- S01B · ANTIINFLAMMATORY AGENTS
- A07E · INTESTINAL ANTIINFLAMMATORY AGENTS
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
- C05A · AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
- CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS
- CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS
Cross-references
Synonyms
- ALPHATREX
- CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
- CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
- CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
- DIPROLENE
- DIPROLENE AF
- DIPROSONE
- Diprolene
- ENSTILAR
- Enstilar
- LOTRISONE
- diproderm
- diprosone
- Betamethasone 17,21-dipropionate
- Betamethasone (as dipropionate)
- Diprospan
- Maxivate
- Rinderon dp
- NSC-758415
- SCH-11460
- Alphatrex
- Betamethasone dipropionate component of enstilar
- Betamethasone dipropionate component of leo-90100
- Betamethasone dipropionate component of lotrisone
- Betamethasone dipropionate component of taclonex
- Betamethasone dipropionate component of wynzora
- Diprolene af
- Diprosone
- Diprolene AF
- Diproderm
- Diprosis
- Psorion
- Rinderon DP
- Sch 11460
- UNII-826Y60901U
- beta-Methasone 17,21-dipropionate
- EINECS 227-005-2
Reported adverse events
- Cardiac arrest
- Cushing's syndrome
- Hypersensitivity
- Skin atrophy
- Erythema
- Rash
- Acne
- Perioral dermatitis
- Pruritus
- Anaphylactoid reaction
- Arachnoiditis
- Bradycardia
Look up BETAMETHASONE DIPROPIONATE in the interactive SynDRA portal →